Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloid Neuropathies, Familial | 6 | 2020 | 180 | 2.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2024 | 1483 | 1.700 |
Why?
|
| Euthanasia | 2 | 2023 | 58 | 1.680 |
Why?
|
| Tissue and Organ Procurement | 2 | 2023 | 986 | 0.950 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2021 | 61 | 0.730 |
Why?
|
| Hemosiderosis | 1 | 2021 | 66 | 0.730 |
Why?
|
| Tomography | 1 | 2022 | 442 | 0.650 |
Why?
|
| Cardiomyopathies | 3 | 2020 | 2056 | 0.610 |
Why?
|
| Myositis | 1 | 2021 | 269 | 0.610 |
Why?
|
| Pneumothorax | 1 | 2022 | 393 | 0.600 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 61 | 0.560 |
Why?
|
| Mental Competency | 1 | 2018 | 179 | 0.550 |
Why?
|
| Prednisone | 1 | 2021 | 1567 | 0.540 |
Why?
|
| Myocardial Contraction | 2 | 2018 | 1525 | 0.520 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 1238 | 0.500 |
Why?
|
| Treatment Refusal | 1 | 2018 | 433 | 0.480 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 2726 | 0.420 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1176 | 0.410 |
Why?
|
| Calcinosis | 1 | 2021 | 1481 | 0.410 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 940 | 0.400 |
Why?
|
| Patient Selection | 1 | 2024 | 4260 | 0.380 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2167 | 0.380 |
Why?
|
| Informed Consent | 1 | 2018 | 1010 | 0.380 |
Why?
|
| Ultrasonography | 1 | 2024 | 6004 | 0.370 |
Why?
|
| Terminal Care | 1 | 2023 | 1770 | 0.370 |
Why?
|
| Echocardiography | 3 | 2020 | 5047 | 0.340 |
Why?
|
| Decision Making | 2 | 2024 | 3953 | 0.310 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2017 | 1417 | 0.270 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2017 | 1389 | 0.270 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3841 | 0.260 |
Why?
|
| Stroke Volume | 3 | 2018 | 5622 | 0.260 |
Why?
|
| Fatty Liver | 1 | 2011 | 809 | 0.240 |
Why?
|
| Heart Failure | 2 | 2020 | 11879 | 0.240 |
Why?
|
| Tissue Donors | 2 | 2023 | 2381 | 0.220 |
Why?
|
| Right to Die | 1 | 2023 | 34 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7477 | 0.210 |
Why?
|
| Databases, Factual | 1 | 2017 | 8080 | 0.190 |
Why?
|
| Diflunisal | 1 | 2020 | 7 | 0.170 |
Why?
|
| Benzoxazoles | 1 | 2020 | 92 | 0.160 |
Why?
|
| Biopsy | 2 | 2022 | 6793 | 0.160 |
Why?
|
| Perfusion | 1 | 2023 | 1401 | 0.160 |
Why?
|
| Withholding Treatment | 1 | 2023 | 620 | 0.160 |
Why?
|
| Survival | 1 | 2019 | 160 | 0.150 |
Why?
|
| Radionuclide Imaging | 2 | 2020 | 2000 | 0.150 |
Why?
|
| Humans | 23 | 2024 | 768166 | 0.150 |
Why?
|
| Benzoates | 1 | 2020 | 213 | 0.150 |
Why?
|
| Sick Leave | 1 | 2019 | 105 | 0.150 |
Why?
|
| Prealbumin | 1 | 2020 | 259 | 0.150 |
Why?
|
| Electric Impedance | 1 | 2022 | 794 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2020 | 563 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 452 | 0.130 |
Why?
|
| Ventricular Function | 1 | 2018 | 405 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 1151 | 0.130 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2020 | 881 | 0.130 |
Why?
|
| Intracranial Hemorrhages | 1 | 2021 | 810 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 979 | 0.120 |
Why?
|
| Male | 12 | 2024 | 364719 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1194 | 0.120 |
Why?
|
| Disease Progression | 3 | 2021 | 13671 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 1798 | 0.110 |
Why?
|
| Middle Aged | 8 | 2024 | 223492 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2020 | 878 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2021 | 1944 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3428 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1596 | 0.090 |
Why?
|
| ROC Curve | 1 | 2018 | 3628 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 2258 | 0.080 |
Why?
|
| Prognosis | 3 | 2020 | 30010 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2020 | 2028 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2020 | 1541 | 0.080 |
Why?
|
| Female | 9 | 2024 | 397192 | 0.080 |
Why?
|
| Electrocardiography | 2 | 2020 | 6412 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 340 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 606 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2022 | 3800 | 0.080 |
Why?
|
| Aged | 5 | 2024 | 171504 | 0.070 |
Why?
|
| Triage | 1 | 2014 | 997 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 12840 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 13014 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 2032 | 0.060 |
Why?
|
| United States | 4 | 2021 | 73039 | 0.060 |
Why?
|
| Hepacivirus | 1 | 2011 | 1344 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39348 | 0.060 |
Why?
|
| Adult | 4 | 2024 | 223646 | 0.060 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 1032 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2024 | 54926 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2011 | 2872 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 10099 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1942 | 0.050 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 1001 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2014 | 2194 | 0.050 |
Why?
|
| Life Style | 1 | 2011 | 3932 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10840 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2011 | 3073 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20760 | 0.040 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2017 | 52 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 65371 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 937 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 59629 | 0.030 |
Why?
|
| Young Adult | 1 | 2022 | 60066 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81762 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 24315 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36743 | 0.020 |
Why?
|
| Incidence | 2 | 2021 | 21538 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 13090 | 0.020 |
Why?
|
| Risk Factors | 2 | 2014 | 74944 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 2735 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 12252 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2145 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 2227 | 0.020 |
Why?
|
| Myocardium | 1 | 2018 | 4788 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2014 | 4541 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8748 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16726 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8509 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 13045 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 14729 | 0.010 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_